Edward P. Balaban

5.4k total citations · 4 hit papers
38 papers, 3.8k citations indexed

About

Edward P. Balaban is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Edward P. Balaban has authored 38 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Hematology. Recurrent topics in Edward P. Balaban's work include Venous Thromboembolism Diagnosis and Management (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Edward P. Balaban is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Edward P. Balaban collaborates with scholars based in United States, Canada and United Kingdom. Edward P. Balaban's co-authors include Gary H. Lyman, Alok A. Khorana, Juan I. Arcelus, Nicole M. Kuderer, Sandra L. Wong, Nigel S. Key, Anna Falanga, Margaret A. Tempero, Ajay K. Kakkar and Christopher R. Flowers and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Cancer.

In The Last Decade

Edward P. Balaban

37 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

2015 968 citations Gary H. Lyman, Kari Bohlke et al. Journal of Clinical Oncology profile →
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

2019 934 citations Nigel S. Key, Alok A. Khorana et al. Journal of Clinical Oncology profile →
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

2013 544 citations Gary H. Lyman, Alok A. Khorana et al. Journal of Clinical Oncology profile →
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update

2023 135 citations Nigel S. Key, Alok A. Khorana et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Edward P. Balaban

Since Specialization

Citations

This map shows the geographic impact of Edward P. Balaban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward P. Balaban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward P. Balaban more than expected).

Fields of papers citing papers by Edward P. Balaban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward P. Balaban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward P. Balaban. The network helps show where Edward P. Balaban may publish in the future.

Co-authorship network of co-authors of Edward P. Balaban

This figure shows the co-authorship network connecting the top 25 collaborators of Edward P. Balaban. A scholar is included among the top collaborators of Edward P. Balaban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward P. Balaban. Edward P. Balaban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Active microbiota persist in dry permafrost and active layer from Elephant Head, Antarctica 2024 ·ISME Communications ·(unknown), (unknown), Elizabeth Trembath‐Reichert, Mary Beth Wilhelm, (unknown), Edward P. Balaban, Christopher P. McKay, (unknown), (unknown), Jacqueline Goordial	8
2	Trajectory Optimization for Adaptive Informative Path Planning with Multimodal Sensing 2024 ·(unknown), Edward P. Balaban, Mykel J. Kochenderfer	1
3	Shaping a gallium alloy and an ionic liquid into spherical mirrors for future liquid-based telescopes—experimental setup and demonstration in parabolic flights 2024 ·Journal of Astronomical Telescopes Instruments and Systems ·(unknown), Khaled Gommed, (unknown), (unknown), Jonathan D. Ericson, (unknown), (unknown), (unknown), Ruslan Belikov, Jay A. Bookbinder, (unknown), Howard Cannon, Edward P. Balaban, Moran Bercovici	0
4	Fluidic shaping and in-situ measurement of liquid lenses in microgravity 2023 ·npj Microgravity ·(unknown), (unknown), (unknown), (unknown), Jonathan Ericson, Khaled Gommed, (unknown), (unknown), Ruslan Belikov, Jay A. Bookbinder, Edward P. Balaban, Moran Bercovici	5
5	Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update breakdown → 2023 ·Journal of Clinical Oncology ·Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke, Agnes Lee, Juan I. Arcelus, Sandra L. Wong, Edward P. Balaban, Christopher R. Flowers, (unknown), Ajay K. Kakkar, Margaret A. Tempero, Shilpi Gupta, Gary H. Lyman, Anna Falanga	135
6	Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update 2021 ·Journal of Clinical Oncology ·Jennifer J. Griggs, Kari Bohlke, Edward P. Balaban, James J. Dignam, Evan Hall, R. Donald Harvey, (unknown), Kelsey Klute, Vicki A. Morrison, Tunghi May Pini, Gary L. Rosner, Carolyn D. Runowicz, Michelle Shayne, Alex Sparreboom, (unknown), Corrine Zarwan, Gary H. Lyman	75
7	New Landscape: Physician Compensation 2020 ·JCO Oncology Practice ·Christian A. Thomas, (unknown), (unknown), (unknown), Linda D. Bosserman, Debra A. Patt, Dhimant Patel, Michael J. Diaz, Thomas Marsland, (unknown), Edward P. Balaban, Elizabeth Blanchard, Gregg E. Franklin, Rahul Seth, Andrew D. Norden	3
8	Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update breakdown → 2019 ·Journal of Clinical Oncology ·Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke, Agnes Lee, Juan I. Arcelus, Sandra L. Wong, Edward P. Balaban, Christopher R. Flowers, Charles W. Francis, (unknown), Ajay K. Kakkar, Mark N. Levine, Howard A. Liebman, Margaret A. Tempero, Gary H. Lyman, Anna Falanga	934
9	Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014 breakdown → 2015 ·Journal of Clinical Oncology ·Gary H. Lyman, Kari Bohlke, Alok A. Khorana, Nicole M. Kuderer, Agnes Y. Lee, Juan I. Arcelus, Edward P. Balaban, Jeffrey Clarke, Christopher R. Flowers, Charles W. Francis, (unknown), Ajay K. Kakkar, Nigel S. Key, Mark N. Levine, Howard A. Liebman, Margaret A. Tempero, Sandra L. Wong, Mark R. Somerfield, Anna Falanga	968
10	A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer 2011 ·Clinical Colorectal Cancer ·Rajesh Sehgal, Barry C. Lembersky, (unknown), (unknown), Edward P. Balaban, (unknown), Patrick M. Kane, Amy Schmotzer, Herbert J. Zeh, Douglas M. Potter, Ramesh K. Ramanathan	3
11	The Effect of Running on Serum and Red Cell Ferritin A Longitudinal Comparison 1995 ·International Journal of Sports Medicine ·Edward P. Balaban, P. G. Snell, J. Stray‐Gundersen, E. P. Frenkel	10
12	Double Modulation of 5-Fluorouracil in the Treatment of Advanced Colorectal Carcinoma: Report of a Trial with Sequential Methotrexate, Intravenous (Loading Dose) Folinic Acid, 5-Fluorouracil, and a Literature Review 1994 ·Cancer Investigation ·Edward P. Balaban, (unknown), Steve Perkins, Richard G. Sheehan, Eugene P. Frenkel, (unknown), Joan M. Bull, Brian Pruitt, Phillip Periman, (unknown), James K. Luce, (unknown)	2
13	The Impact of Dose Intensity of Standard Chemotherapy Regimens in Extensive Stage Small Cell Lung Cancer 1993 ·American Journal of Clinical Oncology ·Richard G. Sheehan, Edward P. Balaban, Eugene P. Frenkel	16
14	Evaluation of bone marrow iron stores in anemia associated with chronic disease: A comparative study of serum and red cell ferritin 1993 ·American Journal of Hematology ·Edward P. Balaban, Richard G. Sheehan, (unknown), John V. Cox, Eugene P. Frenkel	17
15	Detection and Staging of Small Cell Lung Carcinoma with a Technetium-labeled Monoclonal Antibody A Comparison with Standard Staging Methods 1992 ·Clinical Nuclear Medicine ·Edward P. Balaban, Brandy S. Walker, John V. Cox, (unknown), Darrell Salk, Paul G. Abrams, Richard G. Sheehan, Eugene P. Frenkel	19
16	Radionuclide Imaging of Bone Marrow Metastases with a Tc-99m Labeled Monoclonal Antibody to Small Cell Lung Carcinoma 1991 ·Clinical Nuclear Medicine ·Edward P. Balaban, Brandy S. Walker, John V. Cox, (unknown), Paul G. Abrams, Darrell Salk, Richard G. Sheehan, Eugene P. Frenkel	9
17	An eosinophilic fibrohistiocytic lesion of bone marrow in a patient with Hodgkin's disease. A potential for morphologic confusion 1991 ·Cancer ·John V. Cox, Edward P. Balaban, (unknown), Richard G. Sheehan	5
18	The frequency of anemia and iron deficiency in the runner 1989 ·Medicine & Science in Sports & Exercise ·Edward P. Balaban, John V. Cox, P. G. Snell, (unknown), Eugene P. Frenkel	40
19	Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low‐dose cytosine arabinoside 1988 ·American Journal of Hematology ·Edward P. Balaban, John V. Cox, Nancy R. Schneider, (unknown), Barbara Haley, Richard G. Sheehan, Eugene P. Frenkel	4
20	Toxicity of indium-111 on the radiolabeled lymphocyte. 1987 ·PubMed ·Edward P. Balaban, Theodore R. Simon, Eugene P. Frenkel	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact